This highly innovative meeting is meant to cover product development from start to finish with three concurrent programs on Cell & Tissue Banking, Contaminant Control, and the very best in Process Analysis & Automation for a wide-range of applications including vaccines, antibodies, recombinant proteins, viral vectors, and cellular therapies.

This meeting will share the techniques and best practices needed to establish stable and well-characterized cell banks; the latest technologies to prevent, identify, and clear contaminants; as well as the most up-to-date analytical technology, and how it can be used to automate various unit operations and integrated, continuous processes.

We’ll also cover the best applications of single-use components and systems, along with the most powerful single-use sensors.

Please join us for a truly enlightening experience at our 7th Annual Spring Meeting, which will be held March 6–8, 2017 in Washington, DC.

You’ll participate in the most exciting and challenging discussions on the industry’s most difficult applications including viral gene vectors and vaccines, adeno-associated virus (AAV), and other products derived with baculovirus technology, plus cellular therapies and three-dimensional, cellular structures. You can attend any talk you choose from the three concurrent programs, plus you’ll participate in a number of fun and stimulating networking events throughout the meeting that you can attend at no additional cost. This meeting offers unique opportunities to share technology with some of the most talented people in the biotech industry, plus key regulators and essential supply firms.